Denali Therapeutics Inc. (DNLI) climbed 8.64% or 1.58 to $19.86. It is close to 667990 shares traded, which is 146.8% compare to the average total volume 455020. The market cap of DNLI is $1.89 billion. The year to date change is 21.97%. The 52 week price range is from $12.32 to $25.79. Price of DNLI have changed -10.74% during last week. It have changed -3.33% over last month, -14.54% over last 3 months, 7.03% over last 6 months and 18.24% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for DNLI is 17.73. It is -10.73% below current price. The 200-day Moving Averages for DNLI is 18.07. It is -9.01% below current price. The 52-week High is 25.79. It is 29.86% from the current price. The 52-week Low is 12.32. It is -37.97% from current price.
There are some statistics of DNLI. It is has market cap $1.89 billion. The share outstanding is 94.96 million. The average volume is 455020. The percent of top 15 Institution holding is 86.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of DNLI is -41.77%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of DNLI is -36.21%.